Detailseite
Projekt Druckansicht

Die Rolle des Interleukin 6 Rezeptors in Leberschädigung und -Regeneration

Fachliche Zuordnung Gastroenterologie
Immunologie
Förderung Förderung von 2020 bis 2024
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 446322183
 
Erstellungsjahr 2024

Zusammenfassung der Projektergebnisse

The interplay between the immune response and liver damage/regeneration is controlled by the interleukin (IL)-6 family of cytokines. IL-6 is directly involved in liver regeneration. To signal, IL-6 bind to the non-signal transducing IL-6 receptor (IL-6R) followed by Director complex formation with the signal transducing glycoprotein 130 (gp130) receptor. IL-6 deficient mice show a decelerated liver regeneration Carmen Auweiler-Niesen accompanied by increased mortality following partial hepatectomy (PHX). Previously, we showed that IL-6 trans-signalling controls hepatocyte proliferation and thus liver regeneration after PHX via direct and indirect mechanisms. Here, we addressed three main objectives and 1. identified hepatocytes as main target cells for IL-6 type cytokines, 2. rescued the PHX regeneration defect of IL-6R deficient mice by IL-6 type cytokines and 3. showed that constitutive active gp130 signaling restricted to hepatocytes did not rescue the PHX regeneration defect of IL-6R deficient mice. Additionally, in co-operation with the local Düsseldorf group of Prof. E. Lammert we published in Nature Communication that the myeloid-derived growth factor (MYDGF) is a mechanically induced angiocrine signal that induces growth and protection of primary mouse and human hepatocytes.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung